Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory H Bird

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Cell Reports|November 24, 2021
Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic isletsAccalia Fu, Lara van Rooyen, Lindsay Evans, et al.
Molecular Cancer Therapeutics|January 31, 2026
Delivery of ATSP-7041 by Minimally Invasive Nasal Depot (MIND) to Target Diffuse Intrinsic Pontine GliomaAndy J Chua, Valentina Di Francesco, Bethany Tesar, et al.
Molecular Cancer Therapeutics|March 23, 2026
Delivery of ATSP-7041 by Minimally Invasive Nasal Depot (MIND) to Target Diffuse Intrinsic Pontine GliomaAndy J Chua, Valentina Di Francesco, Bethany Tesar, et al.
Nature Chemical Biology|August 19, 2020
Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transferAnn M Cathcart, Gregory H Bird, Thomas E Wales, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
Molecular Cell|March 3, 2018
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCADSilvia Escudero, Elma Zaganjor, Susan Lee, et al.
ACS Chemical Biology|March 23, 2022
Generation of Potent and Stable GLP-1 Analogues Via "Serine Ligation"Paul M Levine, Timothy W Craven, Xinting Li, et al.
Nature Communications|June 27, 2022
Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiencyMichelle S Prew, Christina M Camara, Thomas Botzanowski, et al.
Cell Reports. Medicine|November 27, 2025
A triple-action PROTAC for wild-type p53 cancer therapyGregory H Bird, Utsarga Adhikary, Michael J Schmidt, et al.
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Cell Reports|November 24, 2021
Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic isletsAccalia Fu, Lara van Rooyen, Lindsay Evans, et al.
Molecular Cancer Therapeutics|January 31, 2026
Delivery of ATSP-7041 by Minimally Invasive Nasal Depot (MIND) to Target Diffuse Intrinsic Pontine GliomaAndy J Chua, Valentina Di Francesco, Bethany Tesar, et al.
Molecular Cancer Therapeutics|March 23, 2026
Delivery of ATSP-7041 by Minimally Invasive Nasal Depot (MIND) to Target Diffuse Intrinsic Pontine GliomaAndy J Chua, Valentina Di Francesco, Bethany Tesar, et al.
Nature Chemical Biology|August 19, 2020
Targeting a helix-in-groove interaction between E1 and E2 blocks ubiquitin transferAnn M Cathcart, Gregory H Bird, Thomas E Wales, et al.
The Journal of Experimental Medicine|July 27, 2018
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcomaBjörn Stolte, Amanda Balboni Iniguez, Neekesh V Dharia, et al.
Molecular Cell|March 3, 2018
Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCADSilvia Escudero, Elma Zaganjor, Susan Lee, et al.
ACS Chemical Biology|March 23, 2022
Generation of Potent and Stable GLP-1 Analogues Via "Serine Ligation"Paul M Levine, Timothy W Craven, Xinting Li, et al.
Nature Communications|June 27, 2022
Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiencyMichelle S Prew, Christina M Camara, Thomas Botzanowski, et al.
Cell Reports. Medicine|November 27, 2025
A triple-action PROTAC for wild-type p53 cancer therapyGregory H Bird, Utsarga Adhikary, Michael J Schmidt, et al.
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Pageof 6